These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 18095234)

  • 61. Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone.
    Derosa G; Fogari E; D'Angelo A; Cicero AF; Salvadeo SA; Ragonesi PD; Ferrari I; Gravina A; Fassi R; Fogari R
    J Clin Pharm Ther; 2007 Jun; 32(3):261-8. PubMed ID: 17489878
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).
    Garber AJ; Wahlen J; Wahl T; Bressler P; Braceras R; Allen E; Jain R
    Diabetes Obes Metab; 2006 Jan; 8(1):58-66. PubMed ID: 16367883
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of bee propolis supplementation on glycemic control, lipid profile and insulin resistance indices in patients with type 2 diabetes: a randomized, double-blind clinical trial.
    Samadi N; Mozaffari-Khosravi H; Rahmanian M; Askarishahi M
    J Integr Med; 2017 Mar; 15(2):124-134. PubMed ID: 28285617
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.
    Chiasson JL; Josse RG; Hunt JA; Palmason C; Rodger NW; Ross SA; Ryan EA; Tan MH; Wolever TM
    Ann Intern Med; 1994 Dec; 121(12):928-35. PubMed ID: 7734015
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of colesevelam hydrochloride on glycemia and insulin sensitivity in men with the metabolic syndrome.
    Vega GL; Dunn FL; Grundy SM
    Am J Cardiol; 2011 Oct; 108(8):1129-35. PubMed ID: 21813109
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes.
    Kadoglou NP; Kapelouzou A; Tsanikidis H; Vitta I; Liapis CD; Sailer N
    Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):63-8. PubMed ID: 21031343
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Atorvastatin does not affect insulin sensitivity and the adiponectin or leptin levels in hyperlipidemic Type 2 diabetes.
    Chu CH; Lee JK; Lam HC; Lu CC; Sun CC; Wang MC; Chuang MJ; Wei MC
    J Endocrinol Invest; 2008 Jan; 31(1):42-7. PubMed ID: 18296904
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus.
    Rosenblatt S; Miskin B; Glazer NB; Prince MJ; Robertson KE;
    Coron Artery Dis; 2001 Aug; 12(5):413-23. PubMed ID: 11491207
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Early and long-term effects of acute caloric deprivation in obese diabetic patients.
    Bauman WA; Schwartz E; Rose HG; Eisenstein HN; Johnson DW
    Am J Med; 1988 Jul; 85(1):38-46. PubMed ID: 3291612
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [The role of fat tissue in development of metabolic disorders in patients with diabetes mellitus type 2 and obesity].
    Demidova TIu; Selivanova AV; Ametov AS
    Ter Arkh; 2006; 78(11):64-9. PubMed ID: 17195531
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
    Lancet; 1998 Sep; 352(9131):837-53. PubMed ID: 9742976
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial.
    Henry RR; Gumbiner B; Ditzler T; Wallace P; Lyon R; Glauber HS
    Diabetes Care; 1993 Jan; 16(1):21-31. PubMed ID: 8422777
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effectiveness of carbohydrate counting and Dietary Approach to Stop Hypertension dietary intervention on managing Gestational Diabetes Mellitus among pregnant women who used metformin: A randomized controlled clinical trial.
    Allehdan S; Basha A; Hyassat D; Nabhan M; Qasrawi H; Tayyem R
    Clin Nutr; 2022 Feb; 41(2):384-395. PubMed ID: 34999333
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.
    Jarab AS; Alqudah SG; Mukattash TL; Shattat G; Al-Qirim T
    J Manag Care Pharm; 2012 Sep; 18(7):516-26. PubMed ID: 22971205
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
    Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
    Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Saxagliptin add-on therapy to insulin with or without metformin for type 2 diabetes mellitus: 52-week safety and efficacy.
    Barnett AH; Charbonnel B; Li J; Donovan M; Fleming D; Iqbal N
    Clin Drug Investig; 2013 Oct; 33(10):707-17. PubMed ID: 23949898
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Carbohydrate restriction as the default treatment for type 2 diabetes and metabolic syndrome.
    Feinman RD; Volek JS
    Scand Cardiovasc J; 2008 Aug; 42(4):256-63. PubMed ID: 18609058
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effect of metformin on glycemic control, serum lipids and lipoproteins in diet alone and sulfonylurea-treated type 2 diabetic patients with sub-optimal metabolic control.
    Mughal MA; Jan M; Maheri WM; Memon MY; Ali M
    J Pak Med Assoc; 2000 Nov; 50(11):381-6. PubMed ID: 11126815
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients.
    Breslavsky A; Frand J; Matas Z; Boaz M; Barnea Z; Shargorodsky M
    Clin Nutr; 2013 Dec; 32(6):970-5. PubMed ID: 23561637
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes.
    Rosenstock J; Rood J; Cobitz A; Biswas N; Chou H; Garber A
    Diabetes Obes Metab; 2006 Nov; 8(6):650-60. PubMed ID: 17026489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.